Rocket Pharmaceuticals (RCKT) Earnings Date, Estimates & Call Transcripts $6.33 +0.18 (+2.93%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$6.34 +0.01 (+0.16%) As of 04/17/2025 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Rocket Pharmaceuticals Earnings Summary Upcoming Earnings DateMay. 5Before Market OpensEstimatedConsensus EPS (Mar. 3) -$0.68 Actual EPS (Mar. 3) -$0.62 Beat By $0.06 Rocket Pharmaceuticals issued Q4 2024 earnings on March 3, 2025, reporting an EPS of -$0.62, which topped analysts' consensus estimates of -$0.68 by $0.06. With a trailing EPS of -$2.73, Rocket Pharmaceuticals' earnings are expected to grow next year, from ($2.83) to ($2.22) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K) ReportRCKT Upcoming EarningsRocket Pharmaceuticals' Q1 2025 earnings is scheduled for Monday, May 5, 2025, with a conference call scheduled on Friday, May 2, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Rocket Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rocket Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRCKT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Rocket Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.84-$0.59-$0.72Q2 20253-$0.79-$0.51-$0.63Q3 20252-$0.81-$0.56-$0.69Q4 20253-$0.77-$0.50-$0.61FY 202510-$3.21-$2.16-$2.65Q1 20261-$0.27-$0.27-$0.27Q2 20261-$0.07-$0.07-$0.07Q3 20261$0.05$0.05$0.05Q4 20261$0.25$0.25$0.25FY 20264($0.04)($0.04)($0.04) Rocket Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/5/2025(Estimated)--------3/3/2025Q4 2024-$0.68-$0.62+$0.06-$0.62$0.03M-11/7/2024--$0.78-$0.71+$0.07-$0.71--8/5/2024Q2 2024-$0.72-$0.74 -$0.02-$0.74--5/6/2024Q1 2024-$0.67-$0.66+$0.01-$0.66--2/26/2024Q4 2023-$0.78-$0.64+$0.14-$0.64--11/6/2023Q3 2023-$0.81-$0.75+$0.06-$0.75--8/10/2023Q2 2023-$0.81-$0.82 -$0.01-$0.82--5/4/2023Q1 2023-$0.84-$0.73+$0.11-$0.73-- Rocket Pharmaceuticals Earnings - Frequently Asked Questions When is Rocket Pharmaceuticals's earnings date? Rocket Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based off last year's report dates. Learn more on RCKT's earnings history. Did Rocket Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Rocket Pharmaceuticals (NASDAQ:RCKT) reported ($0.62) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.68) by $0.06. Learn more on analysts' earnings estimate vs. RCKT's actual earnings. How much profit does Rocket Pharmaceuticals generate each year? Rocket Pharmaceuticals (NASDAQ:RCKT) has a recorded net income of -$245.60 million. RCKT has generated -$2.73 earnings per share over the last four quarters. What is Rocket Pharmaceuticals's EPS forecast for next year? Rocket Pharmaceuticals's earnings are expected to grow from ($2.83) per share to ($2.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies ACADIA Pharmaceuticals Earnings Results ImmunityBio Earnings Results Apellis Pharmaceuticals Earnings Results Twist Bioscience Earnings Results MoonLake Immunotherapeutics Earnings Results Amneal Pharmaceuticals Earnings Results Recursion Pharmaceuticals Earnings Results Vericel Earnings Results Mirum Pharmaceuticals Earnings Results Schrödinger Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Archer Aviation Unveils NYC Network Ahead of Key Earnings Report3 Reasons to Like the Look of Amazon Ahead of EarningsTesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions Ahead This page (NASDAQ:RCKT) was last updated on 4/18/2025 by MarketBeat.com Staff From Our Partners100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?Recently, President Trump decided to kill the coin, for good reason. It now costs 4 cents to make a single pen...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RCKT Stock Free RCKT Stock Alerts